Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN)

Today, Nervgen Pharma Corp shares opened at $2.90 and closed at $3.04. Intraday prices ranged from a low of $2.90 to a high of $3.15.

The price boosted 5.19% from the previous day's close of $2.89.

During the day across North America, the TSX Composite closed 1.23% at 22223.67, the S&P 500 closed 0.51% at 5537.02, the Dow Jones Industrial Average closed -0.06% at 39308.00 and the Nasdaq Composite closed 0.84% at 18028.76.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 165,867 shares was traded during the session, with total trades of 224, with an average volume of 116,290 in the last five days.

The TSX-V overall saw 2,918 price advancers against 2,211 declines and 193 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 85.37% in the last 12 months, while in 2024, they have advanced 12.59%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $202.09 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..